Regulatory post‐market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regulatory post‐market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies

Published:2020-11-09 Issue:6 Volume:8 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol. Res. Perspect.

Author:

Hooimeyer Ashleigh¹^ORCID,Bhasale Alice¹^ORCID,Perry Lucy¹^ORCID,Fabbri Alice¹²^ORCID,Mohammad Annim¹^ORCID,McEwin Eliza¹,Mintzes Barbara¹^ORCID

Affiliation:

1. Charles Perkins Centre and School of Pharmacy Faculty of Medicine and Health The University of Sydney Camperdown Australia

2. Centre for Evidence‐Based Medicine Odense (CEBMO) Odense University Hospital and University of Southern Denmark Odense Denmark

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.680

Reference50 articles.

1. A Lifecycle Approach to the Evaluation of FDA Approval Methods and Regulatory Actions

2. Comparative Analysis of Medicines Safety Advisories Released by Australia, Canada, the United States, and the United Kingdom

3. Cardiac effects of non‐cardiac drugs;Hopper I;Aust Prescr,2011

4. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study

5. Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors influencing the implementation of medicine risk communications by healthcare professionals in clinical practice: A systematic review;Research in Social and Administrative Pharmacy;2023-01

2. A sorry tale of unnecessary secrecy about medicine safety;Internal Medicine Journal;2021-10

3. Regulatory authority and clinical acceptability: Physicians' responses to regulatory drug safety warnings;British Journal of Clinical Pharmacology;2021-08-16

4. Cardiac advisories from regulatory agencies differ between countries;Reactions Weekly;2020-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3